Lamordea, MohammedByakika-Kibwika, PaulineMerry, Concepta2022-01-122022-01-122008Lamorde, M., Byakika-Kibwika, P., & Merry, C. (2008). Antiretroviral therapy in developing countries: pharmacologic considerations. Current Opinion in HIV and AIDS, 3(3), 252-257.https://journals.lww.com/co-hivandaids/fulltext/2008/05000/Antiretroviral_therapy_in_developing_countries_.10.aspxhttps://nru.uncst.go.ug/xmlui/handle/123456789/1202The roll-out of antiretroviral drugs in developing countries has become the largest and most ambitious pharmacology project in history. About 2 million people in developing countries now have access to life-saving antiretrovirals, approximately 28% of those in need [1]. Among treated patients, comparable response rates to those seen in western countries have been demonstrated in the first few years of antiretroviral therapy [2]. It is important to sustain these successes by the efficient use of acceptable, efficacious and minimally toxic regimens.enAnti-HIV agentsDeveloping countriesDrug interactionsPharmacokineticsToxicityArticle